MetLife, Inc. $MET Shares Purchased by OFI Invest Asset Management

OFI Invest Asset Management boosted its position in shares of MetLife, Inc. (NYSE:MET) by 2.3% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 406,879 shares of the financial services provider’s stock after buying an additional 9,166 shares during the quarter. OFI Invest Asset Management’s holdings in MetLife were worth $33,515,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of the company. Delta Investment Management LLC grew its position in shares of MetLife by 0.9% during the 1st quarter. Delta Investment Management LLC now owns 14,265 shares of the financial services provider’s stock valued at $1,145,000 after acquiring an additional 133 shares during the period. Ignite Planners LLC boosted its position in MetLife by 2.2% during the second quarter. Ignite Planners LLC now owns 6,366 shares of the financial services provider’s stock worth $491,000 after purchasing an additional 136 shares in the last quarter. Legacy Capital Wealth Partners LLC increased its position in shares of MetLife by 3.2% in the second quarter. Legacy Capital Wealth Partners LLC now owns 4,355 shares of the financial services provider’s stock valued at $350,000 after buying an additional 137 shares in the last quarter. Glenview Trust co increased its position in shares of MetLife by 0.4% in the first quarter. Glenview Trust co now owns 38,333 shares of the financial services provider’s stock valued at $3,078,000 after buying an additional 141 shares in the last quarter. Finally, Abound Wealth Management raised its stake in shares of MetLife by 29.9% during the 3rd quarter. Abound Wealth Management now owns 635 shares of the financial services provider’s stock worth $52,000 after buying an additional 146 shares during the period. Institutional investors and hedge funds own 94.99% of the company’s stock.

MetLife Stock Performance

MET opened at $81.38 on Tuesday. MetLife, Inc. has a twelve month low of $65.21 and a twelve month high of $88.09. The firm has a market capitalization of $53.62 billion, a PE ratio of 15.33, a PEG ratio of 0.78 and a beta of 0.76. The company has a current ratio of 0.18, a quick ratio of 0.18 and a debt-to-equity ratio of 0.54. The firm’s 50-day moving average price is $78.52 and its 200 day moving average price is $78.90.

MetLife (NYSE:MET) last issued its earnings results on Wednesday, November 5th. The financial services provider reported $2.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.30 by $0.07. MetLife had a return on equity of 21.00% and a net margin of 5.30%.The company had revenue of $12.46 billion during the quarter, compared to analysts’ expectations of $18.64 billion. During the same period in the prior year, the business earned $1.95 EPS. The firm’s quarterly revenue was down 5.9% on a year-over-year basis. As a group, sell-side analysts expect that MetLife, Inc. will post 9.65 EPS for the current fiscal year.

MetLife Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 9th. Shareholders of record on Tuesday, November 4th were given a dividend of $0.5675 per share. The ex-dividend date was Tuesday, November 4th. This represents a $2.27 dividend on an annualized basis and a dividend yield of 2.8%. MetLife’s dividend payout ratio (DPR) is currently 42.75%.

Analyst Ratings Changes

Several brokerages recently commented on MET. UBS Group cut their price target on shares of MetLife from $96.00 to $95.00 and set a “buy” rating for the company in a report on Thursday, November 6th. Morgan Stanley set a $101.00 target price on shares of MetLife and gave the company an “overweight” rating in a research report on Monday, December 15th. Wolfe Research upgraded shares of MetLife to a “strong-buy” rating in a research report on Tuesday, September 16th. Piper Sandler lowered shares of MetLife from an “overweight” rating to a “neutral” rating and set a $84.00 price target on the stock. in a research note on Friday, September 19th. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of MetLife in a research note on Monday, December 15th. Two investment analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $95.55.

MetLife Company Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.